Encompass Health Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.9B | $5.4B | $4.8B | $4.3B | $4.0B |
| Operating income | — | — | — | $539.5M | $559.6M |
| Interest expense | $123.2M | $137.4M | $143.5M | $175.7M | $164.3M |
| Pretax income | $953.0M | $749.6M | $607.2M | $450.8M | $505.0M |
| Income tax expense | $192.9M | $150.2M | $132.2M | $100.1M | $101.9M |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M |
| Balance Sheet | |||||
| Cash and equivalents | $72.2M | $85.4M | $69.1M | $21.8M | $49.4M |
| Current assets | $905.9M | $886.9M | $841.8M | $717.2M | $921.4M |
| Total assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B |
| Current liabilities | $836.4M | $841.0M | $656.4M | $575.9M | $748.8M |
| Total liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $4.5B |
| Total debt | $2.5B | $2.5B | $2.7B | $2.8B | $3.3B |
| Stockholders' equity | $2.4B | $2.1B | $1.6B | $1.3B | $1.9B |
| Cash Flow Statement | |||||
| Cash from operations | $1.2B | $1.0B | $850.8M | $705.8M | $715.8M |
| Depreciation and amortization | $327.9M | $299.6M | $273.9M | $243.6M | $219.6M |
| Stock-based compensation | $56.5M | $48.3M | $50.6M | $29.2M | $29.1M |
| Capital expenditure | $736.4M | $642.5M | $583.1M | $564.8M | $524.6M |
| Free cash flow | $439.2M | $360.3M | $267.7M | $141.0M | $191.2M |
| Dividends paid | $71.1M | $62.8M | $60.4M | $99.0M | $112.2M |
| Share repurchases | $158.0M | $31.1M | $0 | $0 | $0 |
Shares outstanding 99.2M · Free float 85.9%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- June 1, 2026 8-K
- May 15, 2026 8-K
- May 11, 2026 8-K
- May 1, 2026 10-Q
- April 30, 2026 8-K
- March 10, 2026 8-K
- February 26, 2026 10-K
- February 20, 2026 8-K/A